Auvelity (bupropion/dextromethorphan) / Axsome Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Auvelity (bupropion/dextromethorphan) / Axsome Therap
NCT03450941: AXS-05 Phase II Trial on Smoking Behavior

Not yet recruiting
2
60
US
AXS-05, Bupropion/dextromethorphan, Bupropion SR, Wellbutrin SR, Zyban SR
James Davis, Axsome Therapeutics, Inc.
Smoking Cessation, Smoking, Cigarette, Nicotine Dependence
12/18
01/19
ASCEND, NCT03595579: Assessing Symptomatic Clinical Episodes in Depression

Checkmark Topline data from ASCEND trial in MDD
Jan 2019 - Jan 2019: Topline data from ASCEND trial in MDD
Checkmark From ASCEND trial for major depressive disorder [screenshot]
Jan 2019 - Jan 2019: From ASCEND trial for major depressive disorder [screenshot]
Completed
2
97
US
AXS-05, Bupropion
Axsome Therapeutics, Inc.
Major Depressive Disorder
01/19
01/19
NCT03471767: AXS-05 Phase II Trial on Smoking Behavior

Completed
2
58
US
AXS-05, Bupropion/dextromethorphan, Bupropion SR, Wellbutrin SR, Zyban SR
James Davis, Axsome Therapeutics, Inc.
Smoking Cessation, Smoking, Cigarette, Nicotine Dependence
03/19
03/19
TARGET, NCT04971291: An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients

Enrolling by invitation
2
312
US
AXS-05, Bupropion SR
Axsome Therapeutics, Inc.
Major Depressive Disorder, Treatment Resistant Depression
07/21
07/21
MERIT, NCT04608396: Mechanistic Evaluation of Response in TRD

Checkmark Data from trial for treatment resistant depression
Aug 2021 - Aug 2021: Data from trial for treatment resistant depression
Checkmark Efficacy and safety data from MERIT trial for treatment of TRD
Aug 2021 - Aug 2021: Efficacy and safety data from MERIT trial for treatment of TRD
Completed
2
44
US
AXS-05, Placebo
Axsome Therapeutics, Inc.
Treatment Resistant Depression, Major Depressive Disorder
07/21
07/21
EVOLVE, NCT04634669: Open-Label Safety Study of AXS-05 in Subjects With TRD

Completed
2
186
US
AXS-05 (dextromethorphan-bupropion)
Axsome Therapeutics, Inc.
Treatment Resistant Depression, Major Depressive Disorder
03/22
03/22
NCT05976646: Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion

Recruiting
1/2
18
US
Placebo, Auvelity
Virginia Commonwealth University, National Institute on Drug Abuse (NIDA)
Addiction, Opioid Use, Substance Use Disorders, Opioid Use Disorder
01/25
01/25

Download Options